PE20011098A1 - Derivados sustituidos de 3,4-bis-(1h-indol-3-il)-pirrol-2,5-diona como agentes antiproliferativos - Google Patents

Derivados sustituidos de 3,4-bis-(1h-indol-3-il)-pirrol-2,5-diona como agentes antiproliferativos

Info

Publication number
PE20011098A1
PE20011098A1 PE2000001386A PE0013862000A PE20011098A1 PE 20011098 A1 PE20011098 A1 PE 20011098A1 PE 2000001386 A PE2000001386 A PE 2000001386A PE 0013862000 A PE0013862000 A PE 0013862000A PE 20011098 A1 PE20011098 A1 PE 20011098A1
Authority
PE
Peru
Prior art keywords
indol
diona
methyl
pirrol
bis
Prior art date
Application number
PE2000001386A
Other languages
English (en)
Inventor
Allen John Lovey
Nader Fotouhi
Norman Kong
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20011098A1 publication Critical patent/PE20011098A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE REFIERE A PIRROLES SUSTITUIDOS DE FORMULA I DONDE R1 Y R1' SON H, ALQUILO, ALQUENILO, ALQUINILO; R2 ES H, NITRO, CIANO, HALOGENO, ALQUILO, ALQUENILO, ALQUINILO, ALCOXILO; R2' ES HETEROARILO, HETEROCICLO, ETILO SUSTITUIDO CON HETEROARILO, ETOXILO SUSTITUIDO CON HETEROARILO, HETEROCICLO. SON COMPUESTOS PREFERIDOS 3-(1-METIL-1H-INDOL-3-IL)-4-(1-METIL-6-TIOFEN-2-IL-1H-INDOL-3-IL)PIRROL-2,5-DIONA; 3-(6-FURAN-2-IL-1-METIL-1H-INDOL-3-IL)-4-(1-METIL-1H-INDOL-3-IL)PIRROL-2,5-DIONA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS INHIBEN LA DIVISION CELULAR EN FASE G2/M DEL CICLO CELULAR Y SON UTILES PARA EL TRATAMIENTO DE TRASTORNOS PROLIFERATIVOS CELULARES CANCER, TUMORES SOLIDOS
PE2000001386A 1999-12-22 2000-12-21 Derivados sustituidos de 3,4-bis-(1h-indol-3-il)-pirrol-2,5-diona como agentes antiproliferativos PE20011098A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17155799P 1999-12-22 1999-12-22

Publications (1)

Publication Number Publication Date
PE20011098A1 true PE20011098A1 (es) 2001-10-26

Family

ID=22624198

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001386A PE20011098A1 (es) 1999-12-22 2000-12-21 Derivados sustituidos de 3,4-bis-(1h-indol-3-il)-pirrol-2,5-diona como agentes antiproliferativos

Country Status (28)

Country Link
US (1) US6281356B1 (es)
EP (1) EP1242409A2 (es)
JP (1) JP2003518112A (es)
KR (1) KR100508741B1 (es)
CN (1) CN1193027C (es)
AR (1) AR027035A1 (es)
AU (1) AU782920B2 (es)
BR (1) BR0016516A (es)
CA (1) CA2394852A1 (es)
CO (1) CO5090902A1 (es)
CZ (1) CZ20022492A3 (es)
HK (1) HK1054382A1 (es)
HR (1) HRP20020536A2 (es)
HU (1) HUP0204572A3 (es)
IL (1) IL150200A0 (es)
JO (1) JO2199B1 (es)
MA (1) MA26860A1 (es)
MX (1) MXPA02006162A (es)
MY (1) MY133682A (es)
NO (1) NO20022927L (es)
NZ (1) NZ519359A (es)
PE (1) PE20011098A1 (es)
PL (1) PL357603A1 (es)
RU (1) RU2261862C2 (es)
UY (1) UY26498A1 (es)
WO (1) WO2001046178A2 (es)
YU (1) YU46302A (es)
ZA (1) ZA200204313B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
TWI324064B (en) 2002-04-03 2010-05-01 Novartis Ag Indolylmaleimide derivatives
GB0303319D0 (en) 2003-02-13 2003-03-19 Novartis Ag Organic compounds
MX2015012456A (es) 2013-03-15 2016-02-03 Plexxikon Inc Compuestos heterociclicos y usos de los mismos.
US20140303121A1 (en) 2013-03-15 2014-10-09 Plexxikon Inc. Heterocyclic compounds and uses thereof
PT3272745T (pt) 2016-07-21 2019-09-27 Inst Farmakologii Polskiej Akademii Nauk Derivados de indol substituídos com imidazolilo que se ligam ao recetor de serotonina 5-ht7 e composições farmacêuticas dos mesmos
EP3694855A1 (en) 2017-10-13 2020-08-19 Plexxikon Inc. Solid forms of a compound for modulating kinases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK278989B6 (sk) 1988-02-10 1998-05-06 F. Hoffmann-La Roche Ag Substituované pyroly, ich použitie na výrobu lieči
US5380746A (en) 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
AU3761393A (en) 1992-03-20 1993-10-21 Wellcome Foundation Limited, The Indole derivatives with antiviral activity
WO1993018766A1 (en) * 1992-03-20 1993-09-30 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
PE91698A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91498A1 (es) 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
EP1064279B1 (en) * 1998-03-17 2003-06-25 F.Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation

Also Published As

Publication number Publication date
NO20022927D0 (no) 2002-06-18
CA2394852A1 (en) 2001-06-28
MXPA02006162A (es) 2002-12-05
NO20022927L (no) 2002-06-18
RU2002119557A (ru) 2004-01-10
UY26498A1 (es) 2001-06-29
EP1242409A2 (en) 2002-09-25
JO2199B1 (en) 2003-12-23
AU782920B2 (en) 2005-09-08
ZA200204313B (en) 2003-08-29
US6281356B1 (en) 2001-08-28
CN1411457A (zh) 2003-04-16
CN1193027C (zh) 2005-03-16
KR20020062365A (ko) 2002-07-25
KR100508741B1 (ko) 2005-08-17
NZ519359A (en) 2004-04-30
MY133682A (en) 2007-11-30
CO5090902A1 (es) 2001-10-30
JP2003518112A (ja) 2003-06-03
PL357603A1 (en) 2004-07-26
YU46302A (sh) 2005-06-10
HUP0204572A2 (en) 2003-05-28
HK1054382A1 (en) 2003-11-28
CZ20022492A3 (cs) 2003-02-12
IL150200A0 (en) 2002-12-01
AR027035A1 (es) 2003-03-12
BR0016516A (pt) 2002-09-17
WO2001046178A2 (en) 2001-06-28
HRP20020536A2 (en) 2004-08-31
MA26860A1 (fr) 2004-12-20
RU2261862C2 (ru) 2005-10-10
HUP0204572A3 (en) 2004-07-28
WO2001046178A3 (en) 2001-12-06
AU3726701A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
PE20010629A1 (es) Derivados de triazolpiridinamina como ligandos de receptores de adenosina
PE20011066A1 (es) PIRIDO [2,3-d] PIRIMIDIN-2,7-DIAMINAS INHIBIDORES DE CINASAS
ES2123149T3 (es) Derivados de perhidroisoindol como antagonistas de la substancia p.
PE20090279A1 (es) Derivados de 3,3-espiroindolinona como agentes antagonistas de mdm2
PE20020753A1 (es) Heteroaromaticos fusionados como activadores de la glucoquinasa
DK1175398T3 (da) Indolinderivater som progesteronantagonister
PE20021006A1 (es) Derivados de 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la proteinquinasa
PE20011047A1 (es) Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas
PE20020506A1 (es) Derivados de pirazol fusionados como inhibidores de la proteina cinasa
DK0925301T3 (da) Höjlipofile camptothecinderivater
PE20010211A1 (es) Compuestos de tiazol y composiciones farmaceuticas para inhibir las quinasas de proteina
PE20001422A1 (es) Antibioticos cetolidos
PE20060380A1 (es) Derivados de pirido-pirimidina en la prevencion y tratamiento de la proliferacion celular
PE20060625A1 (es) Derivados de benzazepina como antagonistas y/o agonistas del receptor h3 de histamina
PE20011098A1 (es) Derivados sustituidos de 3,4-bis-(1h-indol-3-il)-pirrol-2,5-diona como agentes antiproliferativos
PE91598A1 (es) Pirroles sustituidos
UY26226A1 (es) 'derivados de aminopirrolidina heterocíclica como agentes melatonergicos'.- ley 17.164.-
DE60004027D1 (de) Organische-arsenverbindungen
CO5011066A1 (es) Compuestos de triazina
AR027134A1 (es) Derivados de indol.
DE69523595D1 (de) Aryl und heteroaryl alkoxynaphtalen derivate
ES2131015B1 (es) Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
PE20020484A1 (es) Derivados de pirimidina como inhibidores de la enzima conversor de endotelina
FI822706L (fi) Foerfarande foer framstaellning av farmakologiskt aktiva heteroaryloxipropanolaminer
PE20020511A1 (es) Uso de antiprogestinas para la induccion de apoptosis en una celula

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed